Highlights and Quick Summary
- Annual 10Y Operating CF Growth (CAGR) for 2021 was 0.0% (a NaN% decrease from previous year)
- Annual 10Y Operating CF Growth (CAGR) for 2020 was 0.0% (a NaN% decrease from previous year)
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 10Y Operating CF Growth (CAGR) of BioCryst Pharmaceuticals, Inc.
Most recent 10Y Operating CF Growth (CAGR)of BCRX including historical data for past 10 years.Interactive Chart of 10Y Operating CF Growth (CAGR) of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. 10Y Operating CF Growth (CAGR) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | 0.0% |
| 2020 | – | – | – | – | 0.0% |
| 2019 | – | – | – | – | 0.0% |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology